Press release: Ncardia launches Ncyte® Heart in a Box

Published on January 27, 2025
Press release: Ncardia launches Ncyte® Heart in a Box

LEIDEN, THE NETHERLANDS, January 27, 2025: Ncardia, a leading human induced pluripotent stem cell (hiPSC) technology company, today announced the launch of Ncyte® Heart in a Box, a breakthrough 3D cardiac microtissue model designed to drive innovation in cardiovascular research and drug discovery.

Continue reading on website
Other news

Medicine Maker: Accelerating Cell Line Development

January 23, 2025
The essential roles of optimized cell lines and vectors in accelerating bioprocessing.Author: Brett Verstak, Director of Cell Line DevelopmentIn today’s rapidly evolving biopharmaceutical landscape, speed and efficiency in cell line development are more critical than ever. While gene integration methods such as transposase technologies have garnered significant attention, it is essential to not ov

Press release: Ncardia launches Ncyte® Microglia

January 27, 2025
LEIDEN, THE NETHERLANDS, January 27, 2025: Ncardia, a global leader in human induced pluripotent stem cell (hiPSC) technology, today announced the launch of Ncyte® Microglia, a groundbreaking tool to advance research in neurodegenerative diseases and central nervous system (CNS) disorders.